Vir Biotechnology Earnings
NASDAQ: VIRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.80
Vir Biotechnology earnings summary
Vir Biotechnology is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.80. In its most recent report on Aug 5, 2026 (Q2 2026), VIR posted EPS of $0.47. Revenue for the quarter was $238.9 million.
Across the last 16 reports, VIR shares moved an average of 6.0% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
VIR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.47 | — | +4.8% |
| May 6, 2026 | — | $-0.85 | — | -3.6% |
| Jan 12, 2026 | — | $-0.31 | — | +24.8% |
| Nov 5, 2025 | — | $-1.17 | — | +9.7% |
| Aug 6, 2025 | — | $-0.80 | — | +5.1% |
| May 7, 2025 | — | $-0.88 | — | -9.5% |
| Feb 26, 2025 | — | $-0.77 | — | -5.1% |
| Oct 31, 2024 | — | $-1.56 | — | +3.7% |
| Aug 1, 2024 | — | $-1.02 | — | -5.4% |
| May 2, 2024 | — | $-0.48 | — | -9.1% |
| Feb 22, 2024 | — | $-0.86 | — | -2.5% |
| Nov 3, 2023 | — | $-1.22 | — | +0.3% |
| Aug 4, 2023 | — | $-1.45 | — | -1.8% |
| May 8, 2023 | — | $-1.06 | — | +2.6% |
| Feb 28, 2023 | — | $-0.74 | — | -1.0% |
| Nov 3, 2022 | — | $1.30 | — | +6.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.